| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.37 | 9e-24 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |